SCHEMBL19801377

SCHEMBL19801377

CS(C)(C)c1ccccc1-c1cc(-c2ccccc2-c2ccc(-c3ccccn3)cc2)cc(-c2ccccc2S(C)(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EDNRA P25101 3/20 0.48
▸ EDNRB P24530 2/20 0.48
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ SCD O00767 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CCR1 P32246 1/20 0.38
▸ CCR5 P51681 1/20 0.38
▸ CCR8 P51685 1/20 0.38
▸ METAP1 P53582 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794394 0.85 KDM4E (0.52) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL25070279 0.82 TGFBR1 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL18015377 0.80 KDM4E (0.49) EDNRAEDNRBCYP1A2CYP2D6CYP19A1
SCHEMBL21125566 0.79 CYP2A6 (0.46) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL19794350 0.78 CYP1A2 (0.43) EDNRAEDNRBCYP1A2CYP2D6CYP19A1
SCHEMBL19801406 0.78 PTGS2 (0.34) PTGS2KDM4EALOX5APFEN1ABL1
SCHEMBL21125828 0.78 CHEK2 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL18015564 0.78 KDM4E (0.43) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL18573263 0.78 CCR1 (0.53) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL19933801 0.78 KDM4E (0.52) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 — — US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC EDNRA 2101/4885EDNRB 2068/4885CYP1A2 4170/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 EDNRA 2674/4885EDNRB 3765/4885CYP1A2 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback